Large drugmakers are developing fewer antibiotics, analysis finds
Taking stock of the drug industry, from the lab to the medicine chest ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏...Read More
🏥 The 'Bill Parcells' of healthcare
Charlie Martin's playbook for healthcare investing, why providers hesitate on downside risk, and what's next for physician consolida...Read More
Subscribe to:
Comments
(
Atom
)
